These Are the Top 10 Automotive Franchises in 2025
The automotive industry continues to evolve, driven by innovation, convenience and consumer demand for faster, more efficient service. In 2025, the top-performing automotive franchises aren't just changing oil or replacing tires — they're streamlining operations, leveraging mobile platforms and building strong brand loyalty. Whether it's tool trucks that double as mobile showrooms or quick-lube stations that let customers stay in their cars, these franchises offer scalable, proven models for entrepreneurs looking to shift into high gear.
This year's top 10 standouts combine brand recognition, unit growth and franchisee support, making them strong contenders for anyone eyeing a business in the automotive space. From legacy brands with decades of history to up-and-comers shaking up the car-care scene, here are the automotive franchises driving results in 2025 based on the Franchise 500 ranking.
Related: Considering franchise ownership? Get started now to find your personalized list of franchises that match your lifestyle, interests and budget.
1. Snap-On Tools
Founded: 1920
1920 Franchising since: 1991
1991 Overall rank: 16
16 Number of units: 4,674
4,674 Change in units: -2% over 3 years
-2% over 3 years Initial investment: $217,505 - $481,554
$217,505 - $481,554 Leadership: Nick Pinchuk, chairman, president & CEO
Nick Pinchuk, chairman, president & CEO Parent company: Snap-On, Inc.
Snap-on Tools, the #16 franchise on the 2025 Franchise 500, is a mobile tool franchise that serves automotive professionals directly at their place of work. Founded in 1920 and franchising since 1991, the company equips franchisees with fully stocked vans to sell high-quality tools, equipment and diagnostics to mechanics and technicians. Known for durability and brand loyalty, Snap-on offers in-house financing, extensive training and strong franchisor support. Its model focuses on relationship-based sales and exclusive customer routes, making it a popular choice in the automotive sector.
Related: After 14 Years as an RN, She Opened the Business She Always Wanted to See — And Reached $1.3 Million
2. Valvoline Instant Oil Change
Founded: 1986
1986 Franchising since: 1988
1988 Overall rank: 24
24 Number of units: 1,807
1,807 Change in units: +26.1% over 3 years
+26.1% over 3 years Initial investment: $193,375 - $3,485,550
$193,375 - $3,485,550 Leadership: Lori Flees, president & CEO
Lori Flees, president & CEO Parent company: Valvoline Inc.
Valvoline Instant Oil Change offers a streamlined business model built around speed, convenience and brand trust. Launched in 1986 and franchising since 1988, it allows franchisees to deliver quick oil changes and preventative maintenance without customers ever leaving their cars. Backed by one of the most recognizable names in motor oil, franchisees benefit from national advertising, strong training programs and a scalable operational model. It's a turnkey opportunity in the fast-paced world of automotive service.
Related: This Franchise Gives Veterans a $40,000 Head Start to Build Generational Wealth — No Fee Required
3. Tommy's Express Car Wash
Founded: 1969
1969 Franchising since: 2016
2016 Overall rank: 37
37 Number of units: 265
265 Change in units: +128.4% over 3 years
+128.4% over 3 years Initial investment: $4,916,776 - $9,267,763
$4,916,776 - $9,267,763 Leadership: Ryan Essenburg, president & CIO
Ryan Essenburg, president & CIO Parent company: Tommy's Express LLC
Tommy's Express Car Wash is a high-tech, high-throughput tunnel car wash franchise known for its sleek design and efficient operations. Originating in 1969 and franchising since 2016, the brand offers a turnkey model that includes site selection, construction support and training through its dedicated Tommy University. Each location is equipped with advanced technology like license plate recognition and app-based memberships. With a focus on speed, consistency and customer experience, it's built for volume and scalability.
Related: After Decades of Hard Work, This Couple Is Living the Entrepreneurial Dream. Here's How They Achieved Generational Wealth
4. Matco Tools
Founded: 1979
1979 Franchising since: 1993
1993 Overall rank: 46
46 Number of units: 1,903
1,903 Change in units: +0.4% over 3 years
+0.4% over 3 years Initial investment: $107,476 - $340,059
$107,476 - $340,059 Leadership: Mike Dwyer, president
Mike Dwyer, president Parent company: Vontier
Matco Tools is a mobile tool franchise that delivers high-quality tools and equipment directly to automotive professionals. Founded in 1946 and franchising since 1993, Matco equips franchisees with a customized truck that serves as a mobile store, operating within an exclusive territory of about 325 customers. The brand offers in-house financing, comprehensive training and ongoing support. With no royalty fees and a focus on relationship-driven sales, Matco appeals to hands-on entrepreneurs seeking independence and consistent demand in the automotive industry.
Related: How I Turned a Failing Business Into a $1 Million Powerhouse in Just 6 Months
5. Midas
Founded: 1954
1954 Franchising since: 1956
1956 Overall rank: 57
57 Number of units: 1,971
1,971 Change in units: -1% over 3 years
-1% over 3 years Initial investment: $341,650 - $916,890
$341,650 - $916,890 Leadership: Leonard Valentino Jr., president & COO
Leonard Valentino Jr., president & COO Parent company: TBC Corp.
Midas is one of the most recognized names in automotive repair, offering services ranging from oil changes and brake repair to tires and exhaust work. Founded in 1956 and franchising since 1959, Midas combines decades of brand trust with modern systems and support. Franchisees benefit from national advertising, strong training programs and a wide menu of services that drive repeat business. Its flexible shop model allows owners to serve both everyday drivers and fleet customers alike.
Related: After 14 Years as an RN, She Opened the Business She Always Wanted to See — And Reached $1.3 Million
6. Mac Tools
Founded: 1938
1938 Franchising since: 2011
2011 Overall rank: 64
64 Number of units: 1,183
1,183 Change in units: +6.8% over 3 years
+6.8% over 3 years Initial investment: $121,320 - $344,275
$121,320 - $344,275 Leadership: Phil Cox, president/general manager
Phil Cox, president/general manager Parent company: Stanley Black and Decker
Mac Tools is a mobile tool distribution franchise known for delivering professional-grade tools directly to mechanics and technicians. Established in 1938 and franchising since 2011, the brand is part of the Stanley Black & Decker family and supports over 1,000 franchisees across North America. Franchise owners operate fully stocked trucks within protected territories and receive extensive training, business support and marketing resources. Designed for driven, hands-on entrepreneurs, Mac Tools offers a low-overhead, relationship-based business model.
Related: She Quit Her Corporate Job to Sell a Refreshing Summer Staple — Then Made $38,000 the First Week and $1 Million Year 1
7. Cornwell Quality Tools
Founded: 1919
1919 Franchising since: 1997
1997 Overall rank: 72
72 Number of units: 802
802 Change in units: +6.1% over 3 years
+6.1% over 3 years Initial investment: $69,525 - $298,825
$69,525 - $298,825 Leadership: Bob Studenic, president, CEO and director
Bob Studenic, president, CEO and director Parent company: N/A
Cornwell Quality Tools, founded in 1919, is the oldest mobile tool franchise in the United States. Known for delivering professional-grade tools directly to automotive technicians, the brand empowers franchisees — called tool dealers — to operate fully stocked trucks within exclusive territories. There are no upfront franchise fees or royalty payments, making it a lower-cost entry point compared to competitors. With comprehensive training, in-house financing options and strong support systems, Cornwell offers a hands-on business built on trust, quality and customer relationships.
Related: 70 Small Business Ideas to Start in 2025
8. Jiffy Lube
Founded: 1979
1979 Franchising since: 1979
1979 Overall rank: 84
84 Number of units: 2,229
2,229 Change in units: +3.3% over 3 years
+3.3% over 3 years Initial investment: $232,000 - $442,650
$232,000 - $442,650 Leadership: Luke Byerly, president
Luke Byerly, president Parent company: Shell USA
Jiffy Lube is one of the most recognizable names in quick oil changes and automotive maintenance. Founded in 1971, the brand has grown to over 2,000 locations across North America, offering services like oil changes, tire rotations, brake work and fluid exchanges. Backed by the strength of its parent company, Shell, Jiffy Lube provides franchisees with comprehensive training, marketing support and a well-established customer base. It's a trusted, high-volume model built for entrepreneurs seeking steady, recurring business.
Related: How to Turn Big Business Moments Into Lasting Brand Momentum
9. Take 5 Oil Change
Founded: 1984
1984 Franchising since: 2016
2016 Overall rank: 101
101 Number of units: 1,077
1,077 Change in units: +69.3% over 3 years
+69.3% over 3 years Initial investment: $232,794 - $2,033,733
$232,794 - $2,033,733 Leadership: Mo Khalid, EVP & group president of maintenance
Mo Khalid, EVP & group president of maintenance Parent company: Driven Brands Inc.
Take 5 Oil Change is a fast-growing automotive franchise known for its stay-in-your-car oil change model emphasizing speed, convenience and customer service. Founded in 1984 and franchising since 2016, Take 5 has expanded rapidly across the U.S. with a simple, scalable system. Franchisees benefit from strong corporate support, national marketing and a streamlined service offering that minimizes complexity. The brand's modern approach to car care appeals to busy drivers and provides consistent, high-volume revenue opportunities for owners.
10. Big O Tires
Founded: 1962
1962 Franchising since: 1982
1982 Overall rank: 102
102 Number of units: 463
463 Change in units: +0% over 3 years
+0% over 3 years Initial investment: $511,500 - $1,882,500
$511,500 - $1,882,500 Leadership: Gary Skidmore, senior vice president & chief operating officer
Gary Skidmore, senior vice president & chief operating officer Parent company: TBC Corp.
Big O Tires is a well-established tire and automotive service franchise that's been serving drivers since 1962. Known for more than just tires, the brand offers services like oil changes, brake repairs, alignments and battery replacements. Franchising since the early 1980s, Big O operates under the TBC Corporation umbrella and supports franchisees with training, marketing and operational tools. With strong brand recognition and a full-service model, it's a solid option for entrepreneurs seeking a high-volume, customer-focused business.
Related: 'Send a Man Next Time': How an Entrepreneur and Her Daughters Built a $2.5 Million Franchise in a Male-Dominated Field
Ready to break through your revenue ceiling? Join us at Level Up, a conference for ambitious business leaders to unlock new growth opportunities.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Higher electricity demand boosts railroad coal carloads
According to data from the Association of American Railroads, three commodities have driven Class I railroad outperformance in 2025: intermodal containers, coal, and grains. Year-to-date, intermodal volume is up 5% compared to the same stretch in 2024; coal is up 6%, and grains are also up 6%. Union Pacific is moving the most coal: 2025's week 28 number was up 38% over the same week in 2024, but year-to-date, UP has moved 18% more coal carloads than the same period last year. CPKC's year-to-date intermodal traffic numbers are up 11% over 2024, and Canadian National's year-to-date grain volumes are up 17% compared to 2024. Intermodal traffic, which involves the movement of containerized cargo using multiple modes of transportation without handling the cargo itself, remains a vital segment for Class I railroads. This year, the Western U.S. railroads like Union Pacific and BNSF have seen substantial increases in intermodal volumes. Data shows that Union Pacific's intermodal volumes were up by 9% in 2025 compared to 2024, partly driven by growing consumer goods and e-commerce demand, particularly in the west coast ports that serve as entry points for Asian markets. BNSF also saw a similar uptick (5%), reflecting a strong recovery in retail and manufacturing sectors that heavily rely on intermodal services for supply chain distribution. Eastern railroads, namely CSX and Norfolk Southern, are also tapping into the intermodal growth, though their performance varies. CSX reported a marginal increase in intermodal traffic as it continues to enhance its eastern seaboard network efficiency in response to competition from trucking. Conversely, Norfolk Southern has faced a slight downturn, attributed to competitive pressures and network adjustments to improve service reliability. The grain market for railroads is witnessing robust activity, largely due to an increase in U.S. maize exports. Despite tensions with China leading to reduced shipments, American exporters have successfully diversified their markets in Asia, Latin America, and the Mediterranean, contributing to a 9% increase in seaborne grain shipments year-over-year. This diversification has been crucial, as Chinese tariffs imposed in March 2025 have significantly reduced their share of U.S. grain imports from 26% to 10%. Railroads play a crucial role here, with grain carloads showing a 26% rise, reflecting the increase in domestic grain movement. Kansas City Southern, now operating as part of the Canadian Pacific Kansas City network, and Canadian National are particularly benefiting from this shift, aligning their networks to maximize efficiency and capitalize on higher global demand for U.S. grains. The coal sector is another area where railroads are witnessing significant volumes, albeit the dynamics are different. The U.S. coal market, generally in decline due to environmental policies and shifting energy preferences, is experiencing a temporary surge in 2025. This resurgence is linked to heightened domestic electricity demands and strong export demand from Asia, particularly India and China. For instance, Union Pacific and BNSF have both reported noticeable increases in coal shipments as power plants ramp up production to meet high summer electricity demands. April 2025 saw U.S. power plants receiving 28.5 million short tons of coal, up from 24.4 million the previous year, indicating a robust domestic push despite longer-term trends towards renewable energy. International markets are providing a lifeline to U.S. coal exports, which saw their highest levels in six years. Gross exports reached 10 million short tons by June, primarily driven by competitive pricing and unyielding demand from steel production sectors in Asia. This export surge is benefiting eastern railroads as well, such as CSX and Norfolk Southern, which are seeing increased coal traffic leveraging their networks' proximity to export terminals. The Class Is are navigating a dynamic landscape in 2025. Their ability to adapt to shifting economic conditions, leverage intermodal capabilities, and effectively manage traditional sectors like grain and coal are underpinning their surprising outperformance. The post Higher electricity demand boosts railroad coal carloads appeared first on FreightWaves.
Yahoo
19 minutes ago
- Yahoo
Oscar Health (OSCR) Falters on UBS' 'Sell' Reco
We recently published . Oscar Health, Inc. (NYSE:OSCR) is one of the worst-performing companies on Thursday. Oscar Health fell by 9.64 percent on Thursday to close at $13.87 apiece as investor sentiment was dampened by analysts' pessimistic views about the insurance industry. In a market note recently, investment firm UBS recommended investors to sell their shares in Oscar Health, Inc. (NYSE:OSCR), a revision from the 'neutral' stance previously amid the growing instability of the Affordable Care Act. The brokerage firm also lowered its price target for the stock to $11 from $15 previously, marking a 20.7 percent downside from its latest closing price. According to UBS, it now expects enrollments to its programs to drop by 30 percent next year, worse than its previous estimate of 18 percent. A close up of a patient and a healthcare professional engaging in conversation, showing the company's commitment to patient care. Further dampening sentiment, insurance counterpart Elevance Health reported a 24.2-percent drop in net income during the second quarter of the year, while another insurance firm, Centene Corp., withdrew its 2025 earnings forecast earlier this month due to an expected slump in its revenues from commercial plans under the ACA or Obamacare. While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19 minutes ago
- Yahoo
Key Market Players Paving the Way for Advancements in Exosome-Based Diagnostics and Therapeutics
The global exosome research market is anticipated to expand from USD 214.4 million in 2025 to USD 480.6 million by 2030, at a CAGR of 17.5%. This growth is driven by the rising need for advanced diagnostics due to the prevalence of chronic diseases like cancer and neurodegenerative disorders. Exosomes, serving as biomarkers and therapeutic delivery agents, fulfill this demand. The kits & reagents segment is expected to lead growth, aligning with the increased demand for efficient exosome research tools. North America is projected to experience the highest growth, thanks to significant government investments supporting research initiatives. Key players such as Thermo Fisher Scientific and Bio-Techne are profiled. Exosome Research Market Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Exosome Research Market by Offering (Kits, Reagents (Antibodies, Isolation, Purification), Instruments, Services), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem Cell) - Global Forecast to 2030" report has been added to global exosome research market is projected to reach USD 480.6 million by 2030 from USD 214.4 million in 2025, at a CAGR of 17.5% during the forecast period. The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The expansion of the exosome research market is primarily fueled by the escalating incidence of chronic diseases, including cancer, neurodegenerative disorders, and CVDs; this trend underscores the urgent need for novel diagnostic and therapeutic strategies. Exosomes, due to their properties as potential biomarkers and their capacity to facilitate targeted therapeutic delivery, are uniquely positioned to address the increasing demand for advanced disease diagnostics and treatment modalities. The kits & reagents segment is expected to grow at the highest CAGR during the study academic institutions, biotechnology companies, and diagnostic developers delve deeper into the multifaceted roles of exosomes in disease diagnostics and therapeutic interventions, there has been a notable increase in the demand for standardized, user-friendly kits & reagents. These specialized tools play a crucial role in simplifying and expediting the workflows associated with exosome isolation, purification, labeling, and downstream analysis. Exosomes, nano-sized vesicles secreted by cells, have emerged as significant biomarkers in various diseases, necessitating precise handling and standardization offered by commercially available kits helps ensure that researchers can perform these tasks with consistency and reliability, which is vital in both translational research and preclinical development. In particular, reproducibility is critical in scientific research; utilizing validated kits ensures consistent protocols that minimize variability and enhance overall research outcomes. This reliability is particularly pertinent in biomarker discovery and liquid biopsy research, where the identification of accurate biomarkers is paramount for early disease detection and the growing interest in exosome-based diagnostics - especially within oncology for cancer detection and neurodegenerative diseases like Alzheimer's and Parkinson's - laboratories are increasingly opting for ready-to-use reagent systems. These systems facilitate sample preparation, RNA and DNA extraction, and comprehensive cargo profiling, thereby supporting a range of downstream molecular applications. The integration of such standardized tools not only streamlines the research process but also enhances the quality of data generated, ultimately contributing to the advancement of exosome research in clinical settings. As the landscape of diagnostics continues to evolve, the role of such reliable and efficient kits will become even more pronounced, paving the way for breakthroughs in personalized medicine and targeted America is expected to grow at the highest CAGR in the global exosome research market from 2025 to America maintains its leading position in the global exosome research market, primarily due to substantial government investment and support mechanisms. Key organizations such as the National Institutes of Health (NIH) in the United States are pivotal, channeling significant funding into biomedical research, specifically targeting projects centered on exosomes. This financial endorsement empowers researchers to explore novel applications of exosomes in both diagnostics and therapeutics. For example, in June 2024, the National Heart, Lung, and Blood Institute (NHLBI) renewed a USD 12 million Program Project Grant (PPG) to support researchers at the Lewis Katz School of Medicine at Temple investigation focuses on heart cell-derived exosomes and their involvement in cardiac injury and repair processes. This funding facilitates a deeper understanding of the mechanisms by which exosomes contribute to myocardial tissue regeneration, potentially leading to groundbreaking therapeutic strategies. Likewise, in August 2023, the National Cancer Institute (NCI) allocated USD 2.5 million to the Sylvester Comprehensive Cancer Center to advance research on exosome-based biomarkers for prostate cancer detection through urine and blood assays. Such robust government backing not only propels scientific exploration but also fosters collaboration between academic institutions and industry, thereby cultivating a dynamic research ecosystem. This well-capitalized environment accelerates innovation and reinforces North America's status as a frontrunner in exosome research. As a result, the region continues to draw in investments and talent, driving ongoing growth within the exosome research report provides insights on the following pointers: Analysis of key drivers (increasing investment in pharmaceutical & life sciences research, rising cancer prevalence, and increasing interest in exosome-based procedures), restraints (technical complexity of exosome isolation, and regulatory uncertainty in exosome research), opportunities (rising investments in emerging countries for exosome research, growing interest in exosome-based therapeutics, and increasing demand for personalized medicines), and Challenges (lack of gold standard protocols for exosome development and production and limited understanding of cargo loading). Product Development/Innovation: Detailed insights on upcoming products, research and development activities, and new product approvals/launches in the exosome research market. Market Development: Comprehensive information about lucrative markets; the report analyses the market across varied regions. Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the exosome research market. Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/ approvals, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the exosome research market. Key Attributes: Report Attribute Details No. of Pages 325 Forecast Period 2025 - 2030 Estimated Market Value (USD) in 2025 $214.4 Million Forecasted Market Value (USD) by 2030 $480.6 Million Compound Annual Growth Rate 17.5% Regions Covered Global Companies Featured Thermo Fisher Scientific Inc. Qiagen Lonza Danaher Bio-Techne System Biosciences, LLC Amsbio Roosterbio, Inc. Miltenyi Biotec Norgen Biotek Corp. Aethlon Medical, Inc. Creative Medical Technologies Holdings, Inc. Spectris Nanofcm, Inc. Izon Science Limited Capricor Therapeutics, Inc. Anjarium Biosciences AG Ciloa Innovaprep Ilias Biologics Inc. Unchained Labs Rion Inc. Cell Guidance System LLC Inoviq Nx Pharmagen Exopharm Everzom Nanosomix Creative Biolabs For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Exosome Research Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
